217 related articles for article (PubMed ID: 2459037)
1. Influence of hirudin on the consumption of antithrombin III in experimental DIC.
Hauptmann J; Brüggener E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):83-7. PubMed ID: 2459037
[TBL] [Abstract][Full Text] [Related]
2. Effect of heparin, hirudin, and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats.
Hauptmann J; Brüggener E; Markwardt F
Haemostasis; 1987; 17(6):321-8. PubMed ID: 3428717
[TBL] [Abstract][Full Text] [Related]
3. Tissue thromboplastin induced reversible DIC and heparin-enhanced inhibitors in dogs.
Marbet GA; Griffith MJ
Thromb Haemost; 1986 Feb; 55(1):78-85. PubMed ID: 3518133
[TBL] [Abstract][Full Text] [Related]
4. Formation of fibrin monomers in experimental disseminated intravascular coagulation and its inhibition by recombinant hirudin.
Dickneite G; Czech J; Keuper H
Circ Shock; 1994 Apr; 42(4):183-9. PubMed ID: 8055664
[TBL] [Abstract][Full Text] [Related]
5. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic modalities to ameliorate endotoxin induced DIC in the rats.
Bahrami S; Paul E; Redl H; Schlag G
Prog Clin Biol Res; 1989; 308():977-82. PubMed ID: 2780743
[No Abstract] [Full Text] [Related]
7. Heparin-enhanced inhibitors during reversible disseminated intravascular coagulation.
Marbet GA; Griffith MJ; Roberts HR
Scand J Clin Lab Invest Suppl; 1985; 178():95-8. PubMed ID: 3867125
[TBL] [Abstract][Full Text] [Related]
8. Thrombin-hirudin complex stability: a comparison with the thrombin-antithrombin III complex.
Römisch J; Pâques EP
Blood Coagul Fibrinolysis; 1991 Oct; 2(5):643-6. PubMed ID: 1782334
[TBL] [Abstract][Full Text] [Related]
9. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
[TBL] [Abstract][Full Text] [Related]
10. Treatment of disseminated intravascular coagulation (DIC) with all-trans retinoic acid in an endotoxin-induced rat model.
Aoshima K; Asakura H; Yamazaki M; Saito M; Kumabashiri I; Morishita E; Ontachi Y; Mizutani T; Ichino T; Matsuda T
Semin Thromb Hemost; 1998; 24(3):227-31. PubMed ID: 9701452
[TBL] [Abstract][Full Text] [Related]
11. [Antithrombin III activity in relation to multiple administration of various doses of heparin to normal animals].
Kudriashov BA; Pastorova VE; Liapina LA
Vopr Med Khim; 1985; 31(3):37-41. PubMed ID: 4024529
[TBL] [Abstract][Full Text] [Related]
12. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
13. [Antithrombin III substitution in patients in shock].
Vinazzer H; Blauhut B; Bergmann H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):806-16. PubMed ID: 6083957
[TBL] [Abstract][Full Text] [Related]
14. Normal antithrombin-III activity and concentration in experimental disseminated intravascular coagulation.
Müller-Berghaus G; Niepoth M; Rabens-Alles B; Rump E; Murano G
Scand J Clin Lab Invest Suppl; 1985; 178():107-13. PubMed ID: 3867111
[No Abstract] [Full Text] [Related]
15. Endotoxin-induced intravascular coagulation (DIC) and its therapy.
Prager RL; Dunn EL; Kirsh MM; Penner JA
Adv Shock Res; 1979; 2():277-87. PubMed ID: 400581
[TBL] [Abstract][Full Text] [Related]
16. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
Hérault JP; Bernat A; Gaich C; Herbert M
Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
[TBL] [Abstract][Full Text] [Related]
17. A combination of a thrombin inhibitor and dexamethasone prevents the development of experimental disseminated intravascular coagulation in rats.
Elg M; Gustafsson D
Thromb Res; 2006; 117(4):429-37. PubMed ID: 15869787
[TBL] [Abstract][Full Text] [Related]
18. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
[TBL] [Abstract][Full Text] [Related]
19. Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy.
Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1995 Feb; 6(1):60-4. PubMed ID: 7540878
[TBL] [Abstract][Full Text] [Related]
20. [Effects of low molecular weight heparin (FR-860) on the experimental disseminated intravascular coagulation models].
Hamano S; Kinukawa M; Komatsu H; Miyata H; Sakuragawa N
Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):53-62. PubMed ID: 1889762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
